JNJ Articles, Johnson & Johnson - From 05/30/24

Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the iShares U.S. Healthcare ETF (ARCA:IYH), ...

Wednesday, Johnson & Johnson (NYSE:JNJ) announced topline results from Phase 3 MDD3001 clinical trial evaluating the efficacy and safety of sel...

The mass retirement of the boomer generation has been anticipated as one of the most impactful economic events of the 21st century. Economists are ...

J&J will gain full rights to develop, manufacture and commercialize NM26 globally for the treatment of atopic dermatitis and follow-on indicat...

A group of cancer victims has reportedly filed a lawsuit against Johnson & Johnson (NYSE:JNJ), accusing the healthcare gian...

Looking for broad exposure to the Healthcare - Broad segment of the equity market? You should consider the Vanguard Health Care ETF (ARCA:VHT), a p...

In today's fast-paced and competitive business landscape, it is essential for investors and industry enthusiasts to thoroughly analyze compani...

President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA)...

Thursday, Johnson & Johnson (NYSE:JNJ) agreed to acquire Proteologix Inc., a privately held biotechnology company focused o...

On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will be investing a...